Trial Outcomes & Findings for Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing (NCT NCT04776928)

Results Overview

Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

217 participants

Primary outcome timeframe

up to 5 months from enrollment

Results posted on

2023-11-21

Participant Flow

Participant milestones

Participant milestones
Measure	Provider-level Push Report Notifications Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc.	No Intervention Sites who did not sign Exhibit B-1.
Overall Study STARTED	95	122
Overall Study COMPLETED	95	122
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Data on Age was not collected for participants (surgeon participant). MSQC does not collect this data for surgeons.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Provider-level Push Report Notifications n=95 Participants Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc.	No Intervention n=122 Participants Sites who did not sign Exhibit B-1.	Total n=217 Participants Total of all reporting groups
Sex: Female, Male Female	—	—	0 Participants Data on Sex was not collected for participants (surgeon participants). MSQC does not collect this data for surgeons.
Sex: Female, Male Male	—	—	0 Participants Data on Sex was not collected for participants (surgeon participants). MSQC does not collect this data for surgeons.
Race and Ethnicity Not Collected	—	—	0 Participants Race and Ethnicity were not collected from any participant.
Region of Enrollment United States	95 Participants n=95 Participants	122 Participants n=122 Participants	217 Participants n=217 Participants
Prescribing Practices	68.5 Morphine Milligram Equivalents (MME) STANDARD_DEVIATION 56.87 • n=95 Participants	64.3 Morphine Milligram Equivalents (MME) STANDARD_DEVIATION 53.42 • n=122 Participants	66.4 Morphine Milligram Equivalents (MME) STANDARD_DEVIATION 55.21 • n=217 Participants

PRIMARY outcome

Timeframe: up to 5 months from enrollment

Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

Outcome measures

Outcome measures
Measure	Provider-level Push Report Notifications n=95 Participants Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site. Push reports: Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc.	No Intervention n=122 Participants Sites who did not sign Exhibit B-1.
Change in Opioid Prescribed Following the Intervention	62.0 Morphine Milligram Equivalents (MME) Standard Deviation 47.24	58.8 Morphine Milligram Equivalents (MME) Standard Deviation 46.78

Adverse Events

Provider-level Push Report Notifications

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

No Intervention

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Waljee

University of Michigan

Phone: (734) 936-8925

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place